Zatebradine_LCMS_14790_MedChemExpress

Inhibitors, Agonists, Screening LibrariesSafety Data Sheet Revision Date:May-24-2017Print Date:May-24-20171. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name :XL-147Catalog No. :HY-16526CAS No. :934526-89-31.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses :Laboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany:MedChemExpress USATel:609-228-6898Fax:609-228-5909E-mail:sales@1.4 Emergency telephone numberEmergency Phone #:609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixtureGHS Classification in accordance with 29 CFR 1910 (OSHA HCS)Acute toxicity, Oral (Category 4),H302Acute aquatic toxicity (Category 1),H400Chronic aquatic toxicity (Category 1),H4102.2 GHS Label elements, including precautionary statementsPictogramSignal word WarningHazard statement(s)H302 Harmful if swallowed.H410 Very toxic to aquatic life with long lasting effectsPrecautionary statement(s)P264 Wash skin thoroughly after handling.P270 Do not eat, drink or smoke when using this product.P273 Avoid release to the environment.P301 + P312 IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel unwell.P330 Rinse mouth.P391 Collect spillage.P501 Dispose of contents/ container to an approved waste disposal plant.2.3 Other hazardsNone.3. COMPOSITION/INFORMATION ON INGREDIENTS3.1 SubstancesSynonyms:SAR245408; XL 147; XL147; SAR⁻245408; SAR 245408; pilaralisibFormula:C25H25ClN6O4SMolecular Weight:541.02CAS No. :934526-89-34. FIRST AID MEASURES4.1 Description of first aid measuresEye contactRemove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids with fingers to ensure adequate flushing. Promptly call a physician.Skin contactRinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.InhalationImmediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-to-mouth resuscitation.IngestionWash out mouth with water; Do NOT induce vomiting; call a physician.4.2 Most important symptoms and effects, both acute and delayedThe most important known symptoms and effects are described in the labelling (see section 2.2).4.3 Indication of any immediate medical attention and special treatment neededTreat symptomatically.5. FIRE FIGHTING MEASURES5.1 Extinguishing mediaSuitable extinguishing mediaUse water spray, dry chemical, foam, and carbon dioxide fire extinguisher.5.2 Special hazards arising from the substance or mixtureDuring combustion, may emit irritant fumes.5.3 Advice for firefightersWear self-contained breathing apparatus and protective clothing.6. ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency proceduresUse full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate personnel to safe areas.Refer to protective measures listed in sections 8.6.2 Environmental precautionsTry to prevent further leakage or spillage. Keep the product away from drains or water courses.6.3 Methods and materials for containment and cleaning upAbsorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.7. HANDLING AND STORAGE7.1 Precautions for safe handlingAvoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation.7.2 Conditions for safe storage, including any incompatibilitiesKeep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.Recommended storage temperature:Powder-20°C 3 years4°C 2 yearsIn solvent-80°C 6 months-20°C 1 monthShipping at room temperature if less than 2 weeks.7.3 Specific end use(s)No data available.8. EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parametersComponents with workplace control parametersThis product contains no substances with occupational exposure limit values.8.2 Exposure controlsEngineering controlsEnsure adequate ventilation. Provide accessible safety shower and eye wash station.Personal protective equipmentEye protection Safety goggles with side-shields.Hand protection Protective gloves.Skin and body protection Impervious clothing.Respiratory protection Suitable respirator.Environmental exposure controls Keep the product away from drains, water courses or the soil. Cleanspillages in a safe way as soon as possible.9. PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical propertiesAppearance Light yellow to yellow (Solid)Odor No data availableOdor threshold No data availablepH No data availableMelting/freezing point No data availableBoiling point/range No data availableFlash point No data availableEvaporation rate No data availableFlammability (solid, gas)No data availableUpper/lower flammability or explosive limits No data availableVapor pressure No data availableVapor density No data availableRelative density No data availableWater Solubility No data availablePartition coefficient No data availableAuto-ignition temperature No data availableDecomposition temperature No data availableViscosity No data availableExplosive properties No data availableOxidizing properties No data available9.2 Other safety informationNo data available.10. STABILITY AND REACTIVITY10.1 ReactivityNo data available.10.2 Chemical stabilityStable under recommended storage conditions.10.3 Possibility of hazardous reactionsNo data available.10.4 Conditions to avoidNo data available.10.5 Incompatible materialsStrong acids/alkalis, strong oxidising/reducing agents.10.6 Hazardous decomposition productsUnder fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.11.TOXICOLOGICAL INFORMATION11.1 Information on toxicological effectsAcute toxicityClassified based on available data. For more details, see section 2Skin corrosion/irritationClassified based on available data. For more details, see section 2Serious eye damage/irritationClassified based on available data. For more details, see section 2Respiratory or skin sensitizationClassified based on available data. For more details, see section 2Germ cell mutagenicityClassified based on available data. For more details, see section 2CarcinogenicityIARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by ACGIH.NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed carcinogen by NTP.OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed carcinogen by OSHA.Reproductive toxicityClassified based on available data. For more details, see section 2Specific target organ toxicity - single exposureClassified based on available data. For more details, see section 2Specific target organ toxicity - repeated exposureClassified based on available data. For more details, see section 2Aspiration hazardClassified based on available data. For more details, see section 212. ECOLOGICAL INFORMATION12.1 ToxicityNo data available.12.2 Persistence and degradabilityNo data available.12.3 Bioaccumlative potentialNo data available.12.4 Mobility in soilNo data available.12.5 Results of PBT and vPvB assessmentPBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.12.6 Other adverse effectsNo data available.13. DISPOSAL CONSIDERATIONS13.1 Waste treatment methodsProductDispose substance in accordance with prevailing country, federal, state and local regulations.Contaminated packagingConduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.14. TRANSPORT INFORMATIONDOT (US)This substance is considered to be non-hazardous for transport.IMDGUN number: 3077Class: 9Packing group: IIIEMS-No: F-A, S-FProper shipping name: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S.Marine pollutant: Marine pollutantIATAUN number: 3077Class: 9Packing group: IIIProper shipping name: Environmentally hazardous substance, solid, n.o.s.15. REGULATORY INFORMATIONSARA 302 Components:No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.SARA 313 Components:This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.SARA 311/312 Hazards:No SARA Hazards.Massachusetts Right To Know Components:No components are subject to the Massachusetts Right to Know Act.Pennsylvania Right To Know Components:No components are subject to the Pennsylvania Right to Know Act.New Jersey Right To Know Components:No components are subject to the New Jersey Right to Know Act.California Prop. 65 Components:This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive harm.16. OTHER INFORMATIONCopyright 2017 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from handling or from contact with this product.Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

专利名称：川芎嗪衍生物在制备治疗肝纤维化药物中的应用专利类型：发明专利
发明人：郑仕中,陆茵,倪春艳,李伟,吕旋,张峰,严令耕,王爱云申请号：CN201110083086.5
申请日：20110402
公开号：CN102198137A
公开日：
20110928
专利内容由知识产权出版社提供
摘要：本发明属于制药领域，公开了川芎嗪衍生物(2，5-二羟甲基-3，6-二甲基吡嗪)在制备抗肝纤维化药物中的应用。

该川芎嗪衍生物的化学名为2，5-二羟甲基-3，6-二甲基吡嗪，其分子式为CHNO。

本发明研究发现该川芎嗪衍生物从体内和体外实验均表现出良好的抗肝纤维化作用。

申请人：南京中医药大学
地址：210046 江苏省南京市栖霞区仙林大学城仙林大道138号
国籍：CN
更多信息请下载全文后查看。

植 物 生 长 调 节 剂 是 一 类 调 节 和 控 制 植 物 生 长 发 育 的物 质 。随着 科学 技术 和农业 的发展 ， 运用 植 物 生 长 调 节 剂 调 控 植 物 的生 长发 育 和产 量 形 成 已 逐 渐 成 为农 业生 产 中的重要 措 施 『 ｌ 物 生 长调 节 １ 。植
Ｈｅ ｅ ｎｖ ｒｉ ， ａ ｄｎ ７ ０ ２ Ｃ ｉａ） ｂ ｉ ｉｅｓ ｙ Ｂ ｏ ｉｇ １ ０ ， ｈｎ Ｕ ｔ ０
Ａｂ ｔ ａ ｔ Ｔ ｅ ｍｅｈ ｄ ｗ ｓ ｅ ｔｂ ｉ ｅ ｏ ｈ ｅ ａ ａｉ ｎ ａ ｄ ｄ ｔｒ ｎ ｔ ｎ ｏ ｈ ｅ ｉ ｄ ｆｐ ａ ｔ ｇ ｏ ｈ ｒ ｇ ｌｔ ｒ－ ｓｒ ｃ ： ｈ ｔ ｏ ａ ｓａ ｌ ｈ ｄ ｆｒ ｔ ｅ ｓ ｐ ｒ ｔ ｎ ｅｅ ｍｉａｉ ｆｔ ｒ ｅ ｋ ｎ ｓ ｏ ｌｎ ｒｗｔ ｅ ｕａ ｏ ｓ ｏ ｏ ｓ
样量 ：０ Ｌ 采用色谱峰保 留时间定性 ， １． 。 ０ 外标法峰
面 积定 量 。 １３ 标 准 溶液 配 制 ．
准确称取吲哚 乙酸、 吲哚丁酸和 Ｏ Ｌ 乙酸标 一萘
准 品各 ２０ ｇ ．ｍ ，用 甲醇溶解 并定 容 至 ２ Ｌ的具 塞锥 ｍ 形 刻度 管 中 ，配 成质 量 浓度 均 为 ｌ ／ ｍｇ ｍＬ的标 准储
ｃ ｏ ａｏ ｒ ｐ ｙ ｈｒ ｍ ｔ ｇ ａ Ｈ
Ｈａ ｈ ｏ ｊ ， ｈ ｕＪａ － ｅ ， ａ ｇＣ ｉｌ ｇ ｎＣ ａ －ｉ Ｚ ｏ ｉｎ ｋ Ｔ ｎ ｕ－ｉ ａ ｎ
（ ｓａｃ ｅ ｔｒ ｆ Ｈｙ ｉｓ ｎ ｈ ｍｉｒ ａｙｉ， ｅ ａ ｏａｏｙｏ ａｙｉａ Ｓ ｉｎ ｅａ ｄＴ ｃ ｎ ｌｇ ｆ ｂ ｉ ｒｖｎ ｅ Ｒｅｅ ｈＣ ｎｅ ｓｃ ｄＣ ｅ ｓ Ａｎ ｌｓｓ Ｋ ｙＬ ｂ ｒｔｒ ｆ ｒ ｏＰ ａ ｔ ｙ Ａｎ ｌｔ ｌ ｃｅ ｃ ｎ ｅ ｈ ｏｏｙｏ ｅ ｏ ｉｃ ， ｃ Ｈｅ Ｐ

我很高兴能代表您撰写这篇关于“一种西格列汀中亚硝胺类杂质的制备方法”的文章。

在撰写这篇文章之前，我已经对这一主题进行了深入的研究和评估，并准备着手为您写一篇信息量丰富、全面深入的文章。

一种西格列汀中亚硝胺类杂质的制备方法1.背景介绍我准备先从主题的背景介绍开始，引入读者对这一主题的基本了解。

西格列汀是一种常用的药物，但其中亚硝胺类杂质可能对人体健康造成潜在威胁。

制备一种方法来有效去除或限制亚硝胺类杂质的存在至关重要。

2.西格列汀中亚硝胺类杂质的危害和影响在文章的第二部分，我将详细探讨亚硝胺类杂质对西格列汀药物品质和患者健康的潜在危害和影响。

这一部分将会涉及全面的研究成果和数据，以确保读者充分理解这一问题的严重性。

3.现有解决方式的不足为了更深入地探究这一问题，我准备详细分析当前常用的制备方法，揭示它们在去除亚硝胺类杂质方面存在的不足和局限性。

这一部分将引导读者理解为什么需要一种新的、更有效的制备方法。

4.新制备方法的原理和步骤紧我将着重介绍这种新制备方法的原理和具体操作步骤。

这部分将包括详细的化学反应方程式和实验操作流程，确保读者对该方法的操作和原理有清晰的理解。

5.新方法的优势和潜在应用价值接下来，我打算通过对这种新制备方法的优势和潜在应用价值进行分析，向读者展示其在应对亚硝胺类杂质问题上的独特地位和重要意义。

这一部分将包括实验数据和结果的引用，以提供更具说服力的论据。

6.个人观点和总结我将共享我个人对这一主题的观点和理解，并通过全文的回顾和总结来确保读者全面、深刻并灵活地理解这一主题。

以上每个部分都将详细展开，以确保文章的深度和广度兼具。

希望这篇文章能为您提供有价值的信息，并满足您的要求。

我将竭尽全力撰写出一篇高质量的文章，以拓宽您对这一主题的认识和理解。

背景介绍：西格列汀是一种常用的口服降糖药物，用于治疗2型糖尿病。

然而，西格列汀中存在的亚硝胺类杂质可能对人体健康造成潜在威胁。

亚硝胺类化合物是一类致癌的化学物质，它们可能会对身体内的DNA造成损害，增加患癌症的风险。